Charles Schwab’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-375,239
| Closed | -$14.4M | – | 3687 |
|
2023
Q2 | $14.4M | Sell |
375,239
-2,888
| -0.8% | -$111K | ﹤0.01% | 1709 |
|
2023
Q1 | $8.75M | Sell |
378,127
-5,585
| -1% | -$129K | ﹤0.01% | 1935 |
|
2022
Q4 | $10.1M | Buy |
383,712
+9,225
| +2% | +$242K | ﹤0.01% | 1849 |
|
2022
Q3 | $7.36M | Buy |
374,487
+215,075
| +135% | +$4.23M | ﹤0.01% | 2007 |
|
2022
Q2 | $2.79M | Buy |
159,412
+47,937
| +43% | +$839K | ﹤0.01% | 2448 |
|
2022
Q1 | $1.82M | Buy |
111,475
+9,374
| +9% | +$153K | ﹤0.01% | 2674 |
|
2021
Q4 | $1.67M | Buy |
102,101
+17,501
| +21% | +$286K | ﹤0.01% | 2757 |
|
2021
Q3 | $1.08M | Buy |
84,600
+4,609
| +6% | +$58.8K | ﹤0.01% | 2848 |
|
2021
Q2 | $1.13M | Buy |
79,991
+38,774
| +94% | +$548K | ﹤0.01% | 2887 |
|
2021
Q1 | $641K | Buy |
41,217
+19
| +0% | +$295 | ﹤0.01% | 3003 |
|
2020
Q4 | $654K | Buy |
41,198
+7,583
| +23% | +$120K | ﹤0.01% | 2901 |
|
2020
Q3 | $409K | Sell |
33,615
-1,412
| -4% | -$17.2K | ﹤0.01% | 2936 |
|
2020
Q2 | $405K | Buy |
35,027
+7,386
| +27% | +$85.4K | ﹤0.01% | 2913 |
|
2020
Q1 | $379K | Sell |
27,641
-2,293
| -8% | -$31.4K | ﹤0.01% | 2803 |
|
2019
Q4 | $177K | Buy |
29,934
+3,854
| +15% | +$22.8K | ﹤0.01% | 3053 |
|
2019
Q3 | $139K | Sell |
26,080
-35,136
| -57% | -$187K | ﹤0.01% | 3077 |
|
2019
Q2 | $472K | Buy |
61,216
+2,233
| +4% | +$17.2K | ﹤0.01% | 2836 |
|
2019
Q1 | $1.17M | Buy |
58,983
+3,635
| +7% | +$72.4K | ﹤0.01% | 2513 |
|
2018
Q4 | $731K | Sell |
55,348
-3,667
| -6% | -$48.4K | ﹤0.01% | 2634 |
|
2018
Q3 | $2.17M | Buy |
59,015
+12,345
| +26% | +$454K | ﹤0.01% | 2405 |
|
2018
Q2 | $1.63M | Buy |
46,670
+13,856
| +42% | +$485K | ﹤0.01% | 2433 |
|
2018
Q1 | $1.53M | Buy |
32,814
+2,972
| +10% | +$138K | ﹤0.01% | 2411 |
|
2017
Q4 | $1.12M | Sell |
29,842
-5,054
| -14% | -$190K | ﹤0.01% | 2476 |
|
2017
Q3 | $1.86M | Buy |
34,896
+1,828
| +6% | +$97.4K | ﹤0.01% | 2316 |
|
2017
Q2 | $1.89M | Buy |
33,068
+4,046
| +14% | +$231K | ﹤0.01% | 2241 |
|
2017
Q1 | $1.56M | Buy |
29,022
+1,562
| +6% | +$84K | ﹤0.01% | 2280 |
|
2016
Q4 | $1.57M | Buy |
27,460
+1,469
| +6% | +$83.8K | ﹤0.01% | 2275 |
|
2016
Q3 | $1.62M | Buy |
25,991
+12,877
| +98% | +$801K | ﹤0.01% | 2236 |
|
2016
Q2 | $742K | Buy |
13,114
+8,727
| +199% | +$494K | ﹤0.01% | 2448 |
|
2016
Q1 | $281K | Buy |
4,387
+82
| +2% | +$5.25K | ﹤0.01% | 2796 |
|
2015
Q4 | $606K | Buy |
4,305
+104
| +2% | +$14.6K | ﹤0.01% | 2560 |
|
2015
Q3 | $407K | Buy |
4,201
+266
| +7% | +$25.8K | ﹤0.01% | 2701 |
|
2015
Q2 | $597K | Buy |
+3,935
| New | +$597K | ﹤0.01% | 2616 |
|